Gil Fernando da Costa Mendes de Salles

Instituição:

Universidade Federal do Rio de Janeiro

Centro:

Hospital Universitário Clementino Fraga/CCS

Unidade:

Hospital Universitário Clementino Fraga/CCS

Departamento:

Divisão Médica DMD/HU

ORCID:

não disponível no Lattes


Formação:
  • Universidade Federal do Rio de Janeiro

    Clínica Médica | Doutorado | 2001 - 2003
  • Universidade Federal do Rio de Janeiro

    Clínica Médica | Mestrado | 1986 - 1990
  • Universidade Federal do Rio de Janeiro

    | Especialização - Residência medica | 1984 - 1986
  • Universidade Federal do Rio de Janeiro

    Medicina | Graduação | 1978 - 1983
Laboratórios:
Nenhum laboratório cadastrado
Nuvens de Palavras:
Artigos:

(97.47% artigos com DOI)

Titulo DOI Ano
Impact of PNPLA3 and TM6SF2 polymorphisms on the prognosis of patients with MASLD and type 2 diabetes mellitus 10.1111/liv.15845 2024
Body weight variability and the risk of liver-related outcomes in type 2 diabetes and steatotic liver disease: a cohort study 10.1002/oby.24035 2024
Risk of heart failure in ambulatory resistant hypertension: a meta-analysis of observational studies 10.1038/s41440-024-01632-8 2024
Response to Comment on: Risk of heart failure in ambulatory resistant hypertension: a meta-analysis of observational studies 10.1038/s41440-024-01730-7 2024
Prognostic importance of cardiovascular autonomic neuropathy on cardiovascular and mortality outcomes in individuals with type 2 diabetes: The Rio de Janeiro type 2 diabetes cohort 10.1016/j.diabres.2022.110232 2023
Relative prognostic importance of aortic and brachial blood pressures for cardiovascular and mortality outcomes in patients with resistant hypertension and diabetes: a two cohorts prospective study 10.1097/hjh.0000000000003387 2023
Effects of body weight variability on risks of macro- and microvascular outcomes in individuals with type 2 diabetes: The Rio de Janeiro type 2 diabetes cohort 10.1016/j.diabres.2023.110992 2023
Parental History of Type 2 Diabetes Mellitus and PNPLA3 Polymorphism Increase the Risk of Severe Stages of Nonalcoholic Fatty Liver Disease 10.1007/s10620-023-08214-7 2023
Prognostic Impact of On-Treatment Cumulative Ambulatory Blood Pressures for Adverse Macro- and Microvascular Outcomes in Individuals With Type 2 Diabetes: The Rio de Janeiro Type 2 Diabetes Cohort 10.1161/hypertensionaha.123.21514 2023
Prognostic importance of obstructive sleep apnea and CPAP treatment for cardiovascular and mortality outcomes in patients with resistant hypertension: a prospective cohort study 10.1038/s41440-023-01193-2 2023
Effects of Weight Loss and Interaction with Physical Activity on Risks of Cardiovascular Outcomes in Individuals with Type 2 Diabetes 10.3803/enm.2023.1690 2023
Refractory Hypertension: a Narrative Systematic Review with Emphasis on Prognosis 10.1007/s11906-022-01165-w 2022
Prognostic Value of Changes in Aortic Stiffness for Cardiovascular Outcomes and Mortality in Resistant Hypertension: a Cohort Study 10.1161/HYPERTENSIONAHA.121.18498 2022
Prevalence and associated factors of aspiration and severe dysphagia in asymptomatic patients in the late period after open partial laryngectomy: a videofluoroscopic evaluation 10.1007/s00405-021-07231-4 2022
Differential effects of treatment targets on risks of adverse outcomes according to diabetes duration, age and complications: Can these characteristics be used to individualize diabetes treatment? The Rio de Janeiro type 2 diabetes cohort 10.1016/j.jdiacomp.2021.108124 2022
Non-alcoholic fatty liver disease and the impact of genetic, epigenetic and environmental factors in the offspring 10.3748/wjg.v28.i25.2890 2022
Prognostic impact of changes in aortic stiffness for cardiovascular and mortality outcomes in individuals with type 2 diabetes: the Rio de Janeiro cohort study 10.1186/s12933-022-01514-8 2022
MEIOS AUXILIARES DE LOCOMOÇÃO EM INDIVÍDUOS COM DIABETES TIPO 2 10.47222/2526-3544.rbto35781 2021
Diretrizes Brasileiras de Hipertensão Arterial - 2020 10.36660/abc.20201238 2021
Importance of Non-Invasive Liver Fibrosis Scores for Mortality and Complications Development in Individuals with Type 2 Diabetes 10.1016/j.jdiacomp.2021.107879 2021
Traditional and non-traditional risk factors for peripheral artery disease development/progression in patients with type 2 diabetes: the Rio de Janeiro type 2 diabetes cohort study 10.1186/s12933-021-01249-y 2021
Associations Between Achieved Ambulatory Blood Pressures and Its Changes With Adverse Outcomes in Resistant Hypertension 10.1161/HYPERTENSIONAHA.121.17200 2021
Importance of hematological parameters for micro- and macrovascular outcomes in patients with type 2 diabetes: the Rio de Janeiro type 2 diabetes cohort study 10.1186/s12933-021-01324-4 2021
Prognostic impact of liver fibrosis and steatosis by transient elastography for cardiovascular and mortality outcomes in individuals with nonalcoholic fatty liver disease and type 2 diabetes: the Rio de Janeiro Cohort Study 10.1186/s12933-021-01388-2 2021
Prontuário Eletrônico do Paciente na educação médica: percepções de docentes e preceptores 10.1590/1981-5271v45.4-20210251 2021
Associations of the nocturnal blood pressure fall and morning surge with cardiovascular events and mortality in individuals with resistant hypertension 10.1097/hjh.0000000000002775 2021
Prognostic Impact of Home Blood Pressures for Adverse Cardiovascular Outcomes and Mortality in Patients With Resistant Hypertension: A Prospective Cohort Study 10.1161/hypertensionaha.121.18064 2021
The ANDANTE Project: A Worldwide Individual Data Meta-Analysis of the Effect of Sleep Apnea Treatment on Blood Pressure 10.1016/j.arbres.2021.05.002 2021
Effect of Continuous Positive Airway Pressure on Weight and Local Adiposity in Adults with Obstructive Sleep Apnea: A Meta-Analysis 10.1513/annalsats.202101-060oc 2021
Prognostic importance of visit-to-visit blood pressure variability for micro- and macrovascular outcomes in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study 10.1186/s12933-020-01030-7 2020
Posicionamento Brasileiro sobre Hipertensão Arterial Resistente - 2020 10.36660/abc.20200198 2020
Refractory Hypertension and Risks of Adverse Cardiovascular Events and Mortality in Patients With Resistant Hypertension: A Prospective Cohort Study 10.1161/jaha.120.017634 2020
HbA1c variability and long-term glycemic control are linked to peripheral neuropathy in patients with type 1 diabetes 10.1186/s13098-020-00594-4 2020
Prognostic impact of short-term ambulatory blood pressure variability for microvascular and macrovascular outcomes in patients with type 2 diabetes 10.1097/hjh.0000000000002710 2020
Effects of continuous positive airway pressure treatment on aortic stiffness in patients with resistant hypertension and obstructive sleep apnea: A randomized controlled trial 10.1111/jsr.12990 2020
Prognostic Importance of On-Treatment Clinic and Ambulatory Blood Pressures in Resistant Hypertension 10.1161/hypertensionaha.120.14782 2020
Prognostic impact of carotid intima-media thickness and carotid plaques on the development of micro- and macrovascular complications in individuals with type 2 diabetes: the Rio de Janeiro type 2 diabetes cohort study 10.1186/s12933-019-0809-1 2019
Prognostic Impact of Aortic Stiffness in Patients With Resistant Hypertension 10.1161/hypertensionaha.118.12367 2019
COUNTERPOINT: Should Sleep Studies Be Performed for All Patients With Poorly Controlled Hypertension? No 10.1016/j.chest.2019.04.007 2019
HbA1c variability and long-term glycemic control are linked to diabetic retinopathy and glomerular filtration rate in patients with type 1 diabetes and multiethnic background 10.1016/j.jdiacomp.2019.05.022 2019
Rebuttal From Drs Cardoso and Salles 10.1016/j.chest.2019.04.005 2019
PNPLA3 gene polymorphism in Brazilian patients with type 2 diabetes: A prognostic marker beyond liver disease? 10.1016/j.numecd.2019.06.002 2019
Association between high titers of glutamic acid decarboxylase antibody and epilepsy in patients with type 1 diabetes mellitus: A cross-sectional study 10.1016/j.seizure.2019.09.003 2019
Reply to Drs Mantovani and Zusi 10.1016/j.numecd.2019.09.010 2019
Efficacy of diacerein in reducing liver steatosis and fibrosis in patients with type 2 diabetes and non-alcoholic fatty liver disease: A randomized, placebo-controlled trial 10.1111/dom.13643 2019
Prognostic Importance of Resistant Hypertension in Patients With Type 2 Diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study 10.2337/dc19-1534 2019
Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study 10.1186/s12933-018-0677-0 2018
Prognostic impact of the ankle-brachial index on the development of micro- and macrovascular complications in individuals with type 2 diabetes: the Rio de Janeiro Type 2 Diabetes Cohort Study 10.1007/s00125-018-4709-9 2018
Aortic stiffness and ambulatory blood pressure as predictors of diabetic kidney disease: a competing risks analysis from the Rio de Janeiro Type 2 Diabetes Cohort Study 10.1007/s00125-017-4484-z 2018
Usefulness of the vibration perception thresholds measurement as a diagnostic method for diabetic peripheral neuropathy: Results from the Rio de Janeiro type 2 diabetes cohort study 10.1016/j.jdiacomp.2018.05.010 2018
Treatment Adherence and Its Associated Factors in Patients with Type 2 Diabetes: Results from the Rio de Janeiro Type 2 Diabetes Cohort Study 10.1155/2018/8970196 2018
Predictors of Development and Progression of Retinopathy in Patients with Type 2 Diabetes: Importance of Blood Pressure Parameters 10.1038/s41598-017-05159-6 2017
Efficacy and Safety of Diacerein in Patients With Inadequately Controlled Type 2 Diabetes: A Randomized Controlled Trial 10.2337/dc17-0374 2017
Effects of continuous positive airway pressure treatment on aldosterone excretion in patients with obstructive sleep apnoea and resistant hypertension 10.1097/hjh.0000000000001254 2017
A atuação da terapia ocupacional com pacientes com diabetes tipo 2: uma revisão de literatura 10.5935/0104-7795.20170038 2017
Association of carotid intima-media thickness and plaques with diabetic microvascular complications: still much to learn 10.20452/pamw.4059 2017
NAFLD and Increased Aortic Stiffness: Parallel or Common Physiopathological Mechanisms? 10.3390/ijms17040460 2016
Prognostic Effect of the Nocturnal Blood Pressure Fall in Hypertensive PatientsNovelty and Significance 10.1161/hypertensionaha.115.06981 2016
Forearm Resistance-Vessel Dilatation Function During Reactive Hyperemia in Patients With Resistant Hypertension 10.1093/ajh/hpw083 2016
Prognostic Value of C-Reactive Protein in Resistant Hypertension 10.1093/ajh/hpw011 2016
Prevalence of subclinical hypercortisolism in type 2 diabetic patients from the Rio de Janeiro Type 2 Diabetes Cohort Study 10.1016/j.jdiacomp.2016.05.006 2016
Prognostic Importance of C-Reactive Protein in High Cardiovascular Risk Patients With Type 2 Diabetes Mellitus: The Rio de Janeiro Type 2 Diabetes Cohort Study 10.1161/JAHA.116.004554 2016
Prognostic Importance of Ambulatory Blood Pressure Monitoring in Resistant Hypertension: Is It All that Matters? 10.1007/s11906-016-0693-y 2016
Polymorphisms of Leptin (G2548A) and Leptin Receptor (Q223R and K109R) Genes and Blood Pressure During Pregnancy and the Postpartum Period: A Cohort 10.1093/ajh/hpw147 2016
Capítulo 13 - Hipertensão Arterial Resistente 10.5935/abc.20160163 2016
Aortic Stiffness as a Surrogate Endpoint to Micro- and Macrovascular Complications in Patients with Type 2 Diabetes 10.3390/ijms17122044 2016
Caracterização do bullying em estudantes que gaguejam. 2016
Are 2 Years Enough? Exploring Technical Skills Acquisition Among General Surgery Residents in Brazil 10.1080/10401334.2016.1152900 2016
Effect of antihypertensive therapy with angiotensin-converting enzyme inhibitors on chronic periodontitis: a case-control study 10.1111/odi.12551 2016
Aortic stiffness: is it time to be included into clinical diabetes management? 10.1016/j.jdiacomp.2016.06.010 2016
Profile of disabilities and their associated factors in patients with type 2 diabetes evaluated by the Canadian occupational performance measure: the Rio De Janeiro type 2 diabetes cohort study 10.3109/09638288.2015.1111440 2016
Correlates of aortic stiffness progression in patients with resistant hypertension 10.1097/HJH.0000000000000491 2015
Hepatic, Renal and Inflammatory Biomarkers are Positively Associated with Blood Pressure Changes in Healthy Pregnant Women 10.1097/md.0000000000000683 2015
Nitroglycerin-mediated, but not flow-mediated vasodilation, is associated with blunted nocturnal blood pressure fall in patients with resistant hypertension 10.1097/HJH.0000000000000589 2015
Effects of Continuous Positive Airway Pressure Treatment on Clinic and Ambulatory Blood Pressures in Patients With Obstructive Sleep Apnea and Resistant Hypertension: A Randomized Controlled Trial 10.1161/hypertensionaha.114.04852 2015
Development of a risk score to predict sudden death in patients with Chaga's heart disease 10.1016/j.ijcard.2015.03.372 2015
Construction and validation of a surgical skills assessment tool for general surgery residency program 10.1590/0100-69912015006010 2015
Increased aortic stiffness predicts future development and progression of peripheral neuropathy in patients with type 2 diabetes: the Rio de Janeiro Type 2 Diabetes Cohort Study 10.1007/s00125-015-3658-9 2015
Correlates of Aortic Stiffness Progression in Patients With Type 2 Diabetes: Importance of Glycemic Control 10.2337/dc14-2791 2015
Increasing Aortic Stiffness is Predictive of Advanced Liver Fibrosis in Patients with Type 2 Diabetes: the Rio-T2DM Cohort Study 10.1111/liv.12994 2015
Total cholesterol and leptin concentrations are associated with prospective changes in systemic blood pressure in healthy pregnant women 10.1097/hjh.0000000000000037 2014
A reduced heart rate variability is independently associated with a blunted nocturnal blood pressure fall in patients with resistant hypertension 10.1097/HJH.0000000000000068 2014
Non-Alcoholic Fatty Liver Disease and Diabetes: From Physiopathological Interplay to Diagnosis and Treatment 10.3748/wjg.v20.i26.8377 2014
Diagnostic Accuracy of the Berlin Questionnaire in Detecting Obstructive Sleep Apnea in Patients with Resistant Hypertension 10.1097/HJH.0000000000000297 2014
Cardiovascular and renal complications in patients with resistant hypertension. 10.1007/s11906-014-0471-7 2014
Prognostic impact from clinic, daytime, and night-time systolic blood pressure in nine cohorts of 13-844 patients with hypertension 10.1097/HJH.0000000000000355 2014
Prevalence and Associated Factors of Obstructive Sleep Apnea in Patients with Resistant Hypertension 10.1093/ajh/hpu023 2014
Different phenotypes of the NAT2 gene influences hydralazine antihypertensive response in patients with resistant hypertension 10.2217/pgs.13.202 2014
Relationships between reduced heart rate variability and pre-clinical cardiovascular disease in patients with type 2 diabetes 10.1016/j.diabres.2014.07.005 2014
Prognostic importance of baseline and serial glycated hemoglobin levels in high-risk patients with type 2 diabetes: the Rio de Janeiro Type 2 Diabetes Cohort Study 10.1007/s00592-014-0592-0 2014
Is Home Blood Pressure Monitoring Useful in the Management of Patients With Resistant Hypertension? 10.1093/ajh/hpu145 2014
Blood Pressure in Healthy Pregnancy and Factors Associated With No Mid-Trimester Blood Pressure Drop: A Prospective Cohort Study 10.1093/ajh/hpu204 2014
Prognostic impact of sex-ambulatory blood pressure interactions in 10 cohorts of 17-312 patients diagnosed with hypertension 10.1097/hjh.0000000000000435 2014
Prognostic Significance of Baseline Heart Rate and Its Interaction With Beta-Blocker Use in Resistant Hypertension: A Cohort Study 10.1093/ajh/hps004 2013
Serum biomarkers in type 2 diabetic patients with non-alcoholic steatohepatitis and advanced fibrosis 10.1111/j.1872-034X.2012.01106.x 2013
How to use ambulatory blood pressure monitoring in resistant hypertension 10.1038/hr.2013.17 2013
Is blood pressure response to exercise mediated by abnormal glucose and lipid metabolism in normotensive individuals? 10.1038/hr.2013.8 2013
Prognostic Impact of Aortic Stiffness in High-Risk Type 2 Diabetic Patients: The Rio de Janeiro Type 2 Diabetes Cohort Study 10.2337/dc13-0506 2013
Factors associated with abnormal T-wave axis and increased QRS-T angle in type 2 diabetes 10.1007/s00592-013-0483-9 2013
Resistant hypertension: a practical clinical approach 10.1038/jhh.2013.34 2013
Prognostic impact of clinic and ambulatory blood pressure components in high-risk type 2 diabetic patients 10.1097/hjh.0b013e328364103f 2013
Assessment of arterial stiffness in women with gestational diabetes 10.1111/j.1464-5491.2011.03471.x 2012
Factors associated with carotid intima-media thickness and carotid plaques in type 2 diabetic patients 10.1097/HJH.0b013e328352aba6 2012
Prevalence and associated factors of subclinical hypercortisolism in patients with resistant hypertension 10.1097/HJH.0b013e3283521484 2012
Prognostic factors in resistant hypertension: implications for cardiovascular risk stratification and therapeutic management 10.1586/erc.12.58 2012
Validity and Reproducibility of the Sargent Jump Test in the Assessment of Explosive Strength in Soccer Players 10.2478/v10078-012-0050-4 2012
Appropriate Time Interval to Repeat Ambulatory Blood Pressure Monitoring in Patients With White-Coat Resistant Hypertension 10.1161/HYPERTENSIONAHA.111.185405 2012
First Brazilian Position on Resistant Hypertension 10.1590/S0066-782X2012001000002 2012
High fitness is associated with a better cardiovascular risk profile in patients with type 2 diabetes mellitus 10.1038/hr.2011.50. 2011
Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors 10.1111/j.1478-3231.2011.02482.x 2011
Prognostic importance of baseline and serial changes in microalbuminuria in patients with resistant hypertension 10.1016/j.atherosclerosis.2011.01.026 2011
Thresholds of Ambulatory Blood Pressure Associated With Chronic Complications in Type 2 Diabetes 10.1038/ajh.2011.168 2011
Prognostic significance of a reduced glomerular filtration rate and interaction with microalbuminuria in resistant hypertension 10.1097/HJH.0b013e32834adb09 2011
Prognostic impact of baseline and serial changes in electrocardiographic left ventricular hypertrophy in resistant hypertension 10.1016/j.ahj.2010.02.012 2010
Prognostic impact of the ambulatory arterial stiffness index in resistant hypertension 10.1097/HJH.0b013e328339f9e5 2010
Prognostic significance of baseline and serial changes in electrocardiographic strain pattern in resistant hypertension 10.1097/HJH.0b013e32833af39a 2010
Uncontrolled isolated office hypertension is associated with subclinical markers of cardiovascular disease in hypertensive type 2 diabetic patients 10.1038/hr.2010.80 2010
Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus 10.1111/j.1478-3231.2008.01718.x 2009
Prognostic value of ventricular repolarization prolongation in resistant hypertension: a prospective cohort study 10.1097/HJH.0b013e32832720b3 2009
Prognostic Value of Nocturnal Blood Pressure Reduction in Resistant Hypertension 10.1001/archinternmed.2009.68 2009
A blunted decrease in nocturnal blood pressure is independently associated with increased aortic stiffness in patients with resistant hypertension 10.1038/hr.2009.71 2009
Microvascular degenerative complications are associated with increased aortic stiffness in type 2 diabetic patients 10.1016/j.atherosclerosis.2008.12.027 2009
Efficacy of Spironolactone Therapy in Patients With True Resistant Hypertension 10.1161/hypertensionaha.109.140988 2009
Predictors of development and progression of microvascular complications in a cohort of Brazilian type 2 diabetic patients? 10.1016/j.jdiacomp.2007.02.004 2008
Recent Ventricular Repolarization Markers in Resistant Hypertension: Are They Different from the Traditional QT Interval? 10.1038/ajh.2007.4 2008
Ambulatory Arterial Stiffness Index or Pulse Pressure: Which Correlates Better with Arterial Stiffness in Resistant Hypertension? 10.1291/hypres.31.607 2008
Pattern of 24-Hour Ambulatory Blood Pressure Monitoring in Type 2 Diabetic Patients with Cardiovascular Dysautonomy 10.1291/hypres.31.865 2008
Pulse pressure or dipping pattern: which one is a better cardiovascular risk marker in resistant hypertension? 10.1097/HJH.0b013e3282f55021 2008
Prevalence and factors associated with dyslipoproteinemias in Brazilian systemic lupus erythematosus patients 10.1007/s00296-007-0447-x 2008
Initial and accrued damage as predictors of mortality in Brazilian patients with systemic lupus erythematosus: a cohort study 10.1177/0961203308093829 2008
Prognostic Influence of Office and Ambulatory Blood Pressures in Resistant Hypertension 10.1001/archinte.168.21.2340 2008
Gross proteinuria is a strong risk predictor for cardiovascular mortality in Brazilian type 2 diabetic patients 10.1590/S0100-879X2008005000035 2008
Macro and microvascular complications are determinants of increased infection-related mortality in Brazilian type 2 diabetes mellitus patients 10.1016/j.diabres.2006.04.008 2007
Factors associated with microalbuminuria in resistant hypertension? 10.1016/j.ijcard.2006.08.031 2007
Electrocardiographic Strain Pattern and Cardiovascular Prognosis in Hypertension 10.1016/j.amjhyper.2007.05.002 2007
Relation of Left Ventricular Hypertrophy With Systemic Inflammation and Endothelial Damage in Resistant Hypertension 10.1161/HYPERTENSIONAHA.107.093120 2007
Importance of the Electrocardiographic Strain Pattern in Patients With Resistant Hypertension 10.1161/01.HYP.0000236550.90214.1c 2006
Usefulness of QT-interval parameters for cardiovascular risk stratification in type 2 diabetic patients with arterial hypertension 10.1038/sj.jhh.1001815 2005
True Resistant Hypertension: Is it Possible to Be Recognized in the Office? 10.1016/j.amjhyper.2005.06.013 2005
QT-interval parameters are increased in systemic lupus erythematosus patients 10.1191/0961203305lu2225oa 2005
Combined QT Interval and Voltage Criteria Improve Left Ventricular Hypertrophy Detection in Resistant Hypertension 10.1161/01.HYP.0000185517.53179.43 2005
I Diretriz Brasileira de Diagnóstico e Tratamento da Síndrome Metabólica 2005
T-wave axis deviation as an independent predictor of mortality in chronic Chagas' disease 10.1016/j.amjcard.2004.01.040 2004
Mortality and Predictors of Mortality in a Cohort of Brazilian Type 2 Diabetic Patients 10.2337/diacare.27.6.1299 2004
Demographic and clinical characteristics of hypertensive patients in the internal medicine outpatient clinic of a university hospital in Rio de Janeiro 10.1590/S1516-31802004000300003 2004
QT?interval parameters in end?stage renal disease 10.1007/s10286-004-0207-x 2004
Prognostic value of QT interval parameters in type 2 diabetes mellitus Results of a long-term follow-up prospective study 10.1016/S1056-8727(02)00206-4 2003
Electrocardiographic Ventricular Repolarization Parameters in Chronic Chagas' Disease as Predictors of Asymptomatic Left Ventricular Systolic Dysfunction 10.1046/j.1460-9592.2003.t01-1-00190.x 2003
QTc Interval Prolongation Is a Predictor of Future Strokes in Patients With Type 2 Diabetes Mellitus 10.1161/01.STR.0000085084.15144.66 2003
Prognostic Value of QT Interval Parameters for Mortality Risk Stratification in Chagas' Disease: Results of a Long-Term Follow-Up Study 10.1161/01.CIR.0000079174.13444.9C 2003
Multivariate associates of QT interval parameters in diabetic patients with arterial hypertension: importance of left ventricular mass and geometric patterns 10.1038/sj.jhh.1001590 2003
A importância clínica da pressão de pulso 2003
Orlistat in hypertension overweight/obese patients: results of a randomized clinical trial. 10.1097/01.hjh.0000098137.70956.8c 2003
Twenty-four hour ambulatory blood pressure monitoring pattern of resistant hypertension. 10.1097/01.mbp.0000104980.54630.03 2003
Ventricular repolarization in diabetes mellitus: still much to learn 10.1007/s10286-002-0053-7 2002
Clinical determinants of increased QT dispersion in patients with diabetes mellitus 10.1016/S0167-5273(01)00443-0 2001
Mitral Bioprothesis: Clinic, Radiologic, Electrocardiographic and Echocardiographic Evaluation 1988
Hemodynamic action of verapamil in dogs with controlled aortic pressure ¿ Influence of sympathetic activation 10.1016/0014-2999(83)90188-7 1983
Eventos:

(0.00% eventos com DOI)

Titulo DOI Ano
PROGNOSTIC INTERACTION BETWEEN CLINIC AND AMBULATORY BLOOD PRESSURES AND GLYCATED HEMOGLOBIN IN PATIENTS WITH TYPE 2 DIABETES 2014
PROGNOSTIC IMPACT OF CLINIC, DAYTIME, AND NIGHTTIME SYSTOLIC BLOOD PRESSURE IN 9 COHORTS OF 13,844 PATIENTS WITH HYPERTENSION: SYSTEMATIC REVIEW AND META-ANALYSIS 2014
PROGNOSTIC IMPACT OF A GENDER-AMBULATORY BLOOD PRESSURE INTERACTION IN 10 COHORTS OF 17,312 PATIENTS DIAGNOSED WITH HYPERTENSION. SYSTEMATIC REVIEW AND META-ANALYSIS 2014
PROGNOSTIC IMPACT OF AORTIC STIFFNESS IN PATIENTS WITH RESISTANT HYPERTENSION 2014
PATTERNS OF CHANGE IN BLOOD PRESSURE DURING HEALTHY PREGNANCY AND FACTORS ASSOCIATED WITH NO MID-TRIMESTER BLOOD PRESSURE DROP 2014
Avaliação seriada da manuvacuometria em hipertensos resistentes com apnéia obstrutiva do sono antes e após terapia com CPAP. 2013
PROGNOSTIC IMPACT OF AORTIC STIFFNESS IN HIGH-RISK TYPE 2 DIABETIC PATIENTS: THE RIO DE JANEIRO TYPE 2 DIABETES (RIO-T2D) COHORT STUDY 2013
COMPARISON BETWEEN HOME AND AMBULATORY BLOOD PRESSURE MONITORING IN THE DIAGNOSIS AND FOLLOW-UP OF PATIENTS WITH RESISTANT HYPERTENSION 2013
ASSOCIATION BETWEEN OBSTRUCTIVE SLEEP APNEA AND ANTI-HYPERTENSIVE EFFECT OF SPIRONOLACTONE IN RESISTANT HYPERTENSION 2013
PREVALENCE OF SLEEP APNEA AND PATTERN OF POLYSOMNOGRAPHY IN PATIENTS WITH RESISTANT HYPERTENSION 2013
EVALUATION OF BERLIN QUESTIONNAIRE FOR SCREENING OF OBSTRUCTIVE SLEEP APNEA SYNDROME IN PATIENTS WITH RESISTANT HYPERTENTION 2013
OFFICE AND AMBULATORY BLOOD PRESSURE CONTROL IN A COHORT OF PATIENTS WITH RESISTANT HYPERTENSION 2013
A BLUNTED NOCTURNAL BLOOD PRESSURE FALL IS INDEPENDENTLY ASSOCIATED WITH A REDUCED HEART RATE VARIABILITY IN PATIENTS WITH RESISTANT HYPERTENSION 2013
IMPORTANCE OF CLINIC AND AMBULATORY BLOOD PRESSURES AS PREDICTORS OF ALL-CAUSE MORTALITY IN TYPE 2 DIABETES 2012
PROGNOSTIC IMPACT OF CLINIC AND AMBULATORY BLOOD PRESSURES FOR CARDIOVASCULAR OUTCOMES IN TYPE 2 DIABETES 2012
PREVALENCE OF SLEEP APNEA AND PATTERN OF AMBULATORY BLOOD PRESSURE MONITORING IN PATIENTS WITH RESISTANT HYPERTENSION 2012
BERLIN QUESTIONNAIRE FOR SCREENING OF OBSTRUCTIVE SLEEP APNEA SYNDROME IN PATIENTS WITH RESISTANT HYPERTENSION 2012
NITROGLYCERIN-MEDIATED, BUT NOT FLOW-MEDIATED, VASODILATATION IS ASSOCIATED WITH SEVERAL CARDIOVASCULAR RISK FACTORS IN RESISTANT HYPERTENSION 2012
DIFFERENT PHENOTYPES OF THE NAT2 GENE INFLUENCES ANTI-HYPERTENSIVE HYDRALAZINE RESPONSE IN PATIENTS WITH RESISTANT HYPERTENSION 2012
Teste de caminhada de 6 minutos com Consumo de Oxigênio em Pacientes com Hipertensão Arterial Resistente e Síndrome de Apnéia Obstrutiva do Sono 2012
Perfil funcional de pacientes com diabetes tipo 2 de um hospital terciário aferido pela medida Canadense de Desempenho Ocupacional e sus correlação com a qualidade de vida. 2012
Autocuidado em Diabetes Tipo 2 2012
Prevalência de Polineuropatia distal diabética em pacientes com diabetes tipo 2 de um hospital terciário 2012
Specific damages are important predictors of mortality in brazilian patients with systemic lupus erythematosus 2011
Antiphosphollipid syndrome as predictor of mortality in Brazilian patients with systemic lups erythematosus 2011
Prognostic Importance of Heart Rate and Interaction with Beta-Blocker in Resistant Hypertension 2011
Factors associated with carotid intima-media thickness and carotid plaques in type 2 diabetic patients. 2011
Impacto do Tabagismo na Fibrose Hepática em Pacientes Diabéticos com Doença Hepática Gordurosa Não-Alcoólica 2011
Papel da Adiponectina e Citocinas Inflamatórias na Identificação de Formas mais Graves de Doença Hepática Gordurosa Não-Alcoólica 2011
Is Home Blood Pressure Monitoring useful to follow-up of patients with resistant hypertension ? 2011
Prognostic Significance of Baseline Heart Rate and its interaction with with Beta-Blocker use in Resistant Hypertension. 2011
Which is the ideal interval time to repeat ABPM in patients with white-coat resistant hypertension to assure BP control? 2011
Prevalence and Associated Factors of Sub-Clinical Hypercortisolism in Patients with Resistant Hypertension. 2011
Reproducibility of Berlin Questionnaire to Evaluate Risk of Sleep Apnea in Patients with Resistant Hypertension 2011
Berlin questionnaire for screening of sleep apnea syndrome in patients with resistant hypertension 2010
A great white coat effect is associated with a better autonomic balance in patients with resistant hypertension 2010
Prognostic significance of reduced glomerular filtration rate and interaction with microalbuminuria 2010
Can home blood pressure monitoring replace ambulatory blood pressure monitoring in diagnosis and management of resistant hypertension 2010
Prognostic Importance of baseline and serial changes in microalbuminuria in patients with resistant hypertension 2010
Ideal time interval to repeat ambulatory blood pressure monitoring in patients white-coat resistant hypertension 2010
Ambulatory blood pressure paramerers are better correlates of degenerative complications in type 2 diabetes than office blood pressures 2010
Prognostic impact of baseline and serial changes in electrocardiographic left ventricular hypertrophy in resistant hypertension 2009
PROGNOSTIC SIGNIFICANCE OF BASELINE AND SERIAL CHANGES IN ELECTROCARDIOGRAPHIC STRAIN PATTERN IN RESISTANT HYPERTENSION 2009
EFFICACY OF SPIRONOLACTONE THERAPY IN TRUE RESISTANT HYPERTENSION DIAGNOSED BY AMBULATORY BLOOD PRESSURE MONITORING. 2009
PROGNOSTIC IMPORTANCE OF THE AMBULATORY ARTERIAL STIFFNESS INDEX FOR CARDIOVASCULAR RISK STRATIFICATION IN RESISTANT HYPERTENSION 2009
REPRODUCIBILITY OF WHITE-COAT RESISTANT HYPERTENSION DIAGNOSED BY AMBULATORY BLOOD PRESSURE MONITORING 2009
ISOLATED OFFICE HYPERTENSION IS INDEPENDENTLY ASSOCIATED WITH INCREASED CENTRAL AORTIC STIFFNESS IN HYPERTENSIVE PATIENTS WITH TYPE 2 DIABETES. 2009
High physical fitness is independently related to a better glycemic control and cardiovascular risk profile in a type 2 diabetes cohort 2009
Isolated office hypertension (white-coat effect) is independently associated with increased central aortic stiffness in type 2 diabetes 2009
A blunted nocturnal blood pressure reduction is associated with several unfavorable cardiovascular risk markers in type 2 diabetes 2009
Clinical and laboratory correlates of non-alcoholic steatohepatitis and advanced fibrosis in Brazilian type 2 diabetic patients 2009
Prevalence of Histopathological Diagnosis of Steatohepatitis and Fibrosis in Type 2 Diabetes and Interobserver Agreement using Kleiner Classification 2009
Factors associated with increased arterial stiffness in patients with type 2 diabetes mellitus 2008
Relationships between microalbuminuria and 24-hour ambulatory blood pressure monitoring parameters in patients with type 2 diabetes mellitus 2008
Reproducibility of white-coat resistant hypertension diagnosed by ambulatory blood pressure monitoring 2008
Prognostic value of QTc-interval duration for cardiovascular morbidity and mortality in patients with resistant hypertension 2008
Non-dipping pattern is independently associated with increased arterial stiffness in patients with resistant hypertension 2008
Prognostic importance of the nocturnal blood pressure reduction in patients with resistant hypertension 2008
Assessment of efficacy of spironolactone in the treatment of true resistant hypertension evaluated by ambulatory blood pressure monitoring 2008
Prognostic Impact of Office and Ambulatory Blood Pressures in Patients with Resistant Hypertension 2008
Clinical and laboratory correlates of moderate and severe steatosis on ultrasound (US) in Brazilian type 2 diabetic patients 2007
Ambulatory pulse pressure is a better correlate to arterial stiffness than the new ambulatory arterial stiffness index in patients with resistant hypertension 2007
Relation of left ventricular hypertrophy to inflammation and endothelial dysfunction in patients with resistant hypertension 2007
Pulse pressure or nocturnal blood pressure reduction, which one is a better cardiovascular risk marker in resistant hypertension? 2007
Relação de hipertrofia ventricular esquerda com inflamação e disfunção endotelial em pacientes com hipertensão resistente 2007
Pressão de pulso e descenso noturno: qual o melhor marcador de risco cardiovascular em hipertensão resistente? 2007
Índice ambulatorial de rigidez arterial e pressão de pulso de 24 horas: qual o melhor marcador de rigidez arterial em hipertensos resistentes? 2007
Frequencia de achados ultra-sonográficos de esteatose em pacientes com diabetes mellitus tipo 2. 2007
Factors associated with abnormal T-wave axis deviation in patients with resistant hypertension 2006
Factors associated with prolonged transmural dispersion of ventricular repolarization in resistant hypertension 2006
Pattern of 24-hour ambulatory blood pressure monitoring in type 2 diabetic patients with and without cardiovascular dysautonomy 2006
Prevalence of primary aldosteronism and computerized findings in adrenal glands in patients with resistant hypertension 2006
C-reative protein distribution in patients with resistant hypertension 2006
Is nocturnal blood pressure fall a good cardiovascular risk marker in resistant hypertension? 2006
Cardiovascular factors associated with microalbuminuria in non-diabetic patients with resistant hypertension 2005
Medication adherence in resistant hypertension - comparing three strategies of evaluation 2005
Processo de Seleção para a Residência Médica: um Modelo Inovador 2005
Usefullness of QT-interval parameters for cardiovascular risk stratification in hypertensive type 2 diabetic patients: results of a long-term follow-up prospective study. 2004
Microalbuminuria and other cardiovascular risk factors in patients with resistant hypertension 2004
Assessment of blood pressure control in resistant hypertensive patients with ambulatory blood pressure monitoring. 2004
Predictors of left ventricular hypertrophy in patients with resistant hypertension. 2004
Correlates of QT-interval parameters in patients with resistant hypertension: role of left ventricular hypertrophy and geometric patterns. 2004
Prevalence of dyslipidemia and its associated risk factors in Brazilian systemic lupus erythematosus patients 2004
Preditores de microalbuminuria em pacientes portadores de hipertensão arterial resistente 2004
Correlação de parâmetros do intervalo QT em pacientes com hipertensão resistente: papel da hipertrofia ventricular esquerda e padrões geométricos do VE. 2004
Preditores de hipertrofia ventricular esquerda em pacientes portadores de hipertensão arterial resistente 2004
Prevalência de dislipidemia e seus fatores de risco em pacientes com lupus eritematoso 2004
Ação dos antimaláricos no perfil lipídico de pacientes com lupus eritematoso sistêmico 2004
24-hour ambulatory blood pressure monitoring pattern of resistant hypertension. 2002
Predictive factors for resistant hypertension in hypertensive patients under intensive treatment. 2002
QT dispersion and resistant hypertension: correlation with echocardiographic, ambulatory blood pressure monitoring and electrocardiographic data. 2002
Predictors of left ventricular hypertrophy in patients with resistant hypertension 2002
Hipertensão arterial refratária: parâmetros de monitorização ambulatorial da pressão arterial (MAPA) e lesões de órgãos-alvo. 2002
Perfil dos pacientes acompanhados pelo programa de hipertensão arterial do HUCFF/UFRJ 2002
Electrocardiographic repolarization parameters in hypertensive diabetic patients: relation to left ventricular mass and geometric patterns 2002
Parâmetros eletrocardiográficos da repolarização ventricular como preditores de disfunção sistólica ventricular esquerda assintomática em Doença de Chagas 2002
Valor prognóstico dos parâmetros eletrocardiográficos da repolarização ventricular para a estratificação de risco de mortalidade em Doença de Chagas 2002
Prevalence and Characteristics of Resistant Hypertension (RH) and White Coat Effect (WCE) diagnosed by Ambulatory Blood Pressure Monitoring (ABPM) 2001
The effect of Orlistat + Diet compared with diet alone in anthropometric measures, glucose and lipids levels of hypertensive, overweight/obese patients. 2001
Assessment of Ambulatory Blood Pressure Monitoring (ABMP) in Resistant Hypertension (RH) and White Coat Effect (WCE) With or Without Left Ventricular Hypertrophy (LVH) 2001
Effect of orlistat + diet compared with diet alone in anthropometric measures and blood pressure of hypertensive overweight/obese patients 2001
Dispersão do intervalo QT do eletrocardiograma em pacientes diabéticos 2000
Avaliação evolutiva dos pacientes portadores de hipertensão arterial refratária acompanhados non Serviço de Clínica Médica do Hospital Universitário Clementino Fraga Filho da Universidade Federal do Rio de Janeiro (HUCFF-UFRJ) 2000
Hipertensão arterial refratária: avaliação evolutiva de 227 pacientes em acompanhamento ambulatorial. 2000
Perfil dos pacientes hipertensos acompanhados no ambulatório de Clínica Médica do Hospital Universitário Clementino Fraga Filho da Universidade Federal do Rio de Janeiro 2000
Eficácia do tratamento anti-hipertensivo no ambulatório do serviço de Clínica Médica do Hospital Universitário Clementino Fraga Filho - UFRJ 2000
Avaliação evolutiva da terapêutica anti-hipertensiva e controle dos níveis tensionais em pacientes portadores de hipertensão arterial refratária do ambulatório de Clínica Médica do Hospital Universitário Clementino Fraga Filho da Universidade Federal do Rio de Janeiro 2000
Linfoma Não-Hodgkin com Infiltração Vesical 2000
Dispersão do intervalo QT do eletrocardiograma em diabéticos 1999
Avaliação das alterações eletrocardiográficas e do intervalo QT em diabéticos 1999
Eficácia do tratamento anti-hipertensivo no ambulatório do serviço de clínica médica do HUCFF - UFRJ 1999
Perfil clínico de pacientes com diabetes mellitus não insulino dependente (DMNID) em acompanhamento no Hospital Universitário Clementino Fraga Filho da Universidade Federal do Rio de Janeiro (HUCFF-UFRJ) 1999
Perfil dos pacientes hipertensos acompanhados no ambulatório de Clínica Médica do Hospital Universitário Clementino Fraga Filho da Universidade Federal do Rio de Janeiro (HUCFF-UFRJ). 1999
Dispersão do intervalo QT em diabéticos com hipertensão arterial como precursor de hipertrofia ventricular esquerda. 1999
Importância da precisão do registro da pressão arterial 1999
Perfil dos pacientes hipertensos acompanhados no ambulatório de Clínica Médica do Hospital Universitário Clementino Fraga Filho da Universidade Federal do Rio de Janeiro 1999
Vasculite Retiniana e Nefropatia: Relato de Caso 1999
Vasculite Sistêmica Necrotizante Associada a Tuberculostáticos: Relato de Caso 1999
Avaliação Cardiovascular Pré-Operatória em Pacientes Submetidos a Cirurgia Vascular 1999
TIPS: Shunt Porto-Sistêmico Intra-Hepático Transjugular - Análise de 15 Casos 1999
Análise de 191 Casos de Carcinoma Hepatocelular no Hospital Universitário Clementino Fraga Filho con ênfase na Associação com Hepatite Viral 1999
Letalidade associada e incidência de infecção por Staphylococus Aureus resistentes a meticilina internados no HMSF 1997
Implicação do Primeiro Episódio de Peritonite Bacteriana Expontânea na Sobrevida de Pacientes Cirróticos com Ascite 1997
Síndrome de Koogan: Relato de um Caso e Revisão da Literatura 1997
Complicações Clínicas em Pós-Operatório de Cirurgias Ortopédicas 1997
Perfil de Morbi-Mortalidade dos Pacientes Internados no Serviço de Clínica Médica do Hospital Clementino Fraga Filho da UFRJ 1997
Digital e Mortalidade Imediata Pós-Infarto Agudo do Miocárdio: Estudo Retrospectivo 1997
Efeitos hemodinâmicos do verapamil -avaliação crítica 1981
Efeitos hemodinâmicos do verapamil -estudo comparativo com o nitroprussiato 1981
Efeitos hemodinâmicos do verapamil -avaliação critica 1981
Efeitos hemodinâmicos do verapamil - estudo comparativo com nitroprussiato de sódio 1981
Detection and quantification of small left-to right shunt by the indicator-dilution phase-plane technique 1981
Avaliação através de balonete intra-aórtico da participação de reflexos pressorreptores na resposta hemodinâmica ao verapamil 1980
Análise dos transientes iniciais da frequência cardíaca em exercícios dinâmicos de diferentes intensidades 1980
Participação dos Pressoreceptores Aórticos e Carotídeos na Resposta Hemodinâmica ao Verapamil 1980
Detection and Quantification of Cardiovascular Shunts: a New Analytical Method 1980
Publicações:
Minha Rede: